Compounds > epirubicin
Page last updated: 2024-08-23

epirubicin and Proteinuria

epirubicin has been researched along with Proteinuria in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagnardi, V; Balduzzi, A; Bertolini, F; Cardillo, A; Colleoni, M; Goldhirsch, A; Mancuso, P; Montagna, E; Orlando, L; Scarano, E; Torrisi, R; Veronesi, P; Viale, G1
Hofmann, J; Müller, T; Steck, T1
Antongiovanni, V; Balconi, F; Ballerini, L; Bertazzoli, C; Lux, B; Magrini, U; Rovero, C1

Other Studies

3 other study(ies) available for epirubicin and Proteinuria

ArticleYear
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
    Anti-cancer drugs, 2009, Volume: 20, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Hypertension; Infusions, Intravenous; Letrozole; Mastectomy; Middle Aged; Nitriles; Paclitaxel; Prognosis; Proteinuria; Radiotherapy, Adjuvant; Triazoles

2009
Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 1996, Volume: 67, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Anticonvulsants; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Eclampsia; Epirubicin; Female; Fluorouracil; Gestational Age; Humans; Hypertension; Placenta; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Proteinuria; Thrombocytopenia; Trophoblasts

1996
Experimental systemic toxicology of 4'-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agent.
    Toxicology and applied pharmacology, 1985, Volume: 79, Issue:3

    Topics: Animals; Antineoplastic Agents; Body Weight; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Epirubicin; Erythrocyte Count; Female; Heart; Lethal Dose 50; Leukocyte Count; Liver; Liver Function Tests; Male; Mice; Mice, Inbred Strains; Organ Size; Proteinuria; Rats; Rats, Inbred Strains; Testis; Thymus Gland

1985